Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations

European Journal of Clinical Investigation

Volumn 29, Issue 8, 1999, Pages 679-686

  Maslowska, M ^a   Vu, H ^a   Phelis, S ^a   Sniderman, A D ^a   Rhode, B M ^b,c   Blank, D ^b   Cianflone, K ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c Division of Surgery   (Canada)

Author keywords

Human adipose tissue; Lipoproteins; Plasma complement C3a; Triacylglycerol synthesis

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPSIN; COMPLEMENT COMPONENT C3A; LIPID; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; BLOOD PROTEINS; CASE-CONTROL STUDIES; COMPLEMENT C3A; COMPLEMENT FACTOR D; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; REFERENCE VALUES; SERINE ENDOPEPTIDASES;

EID: 0032765317     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00514.x     Document Type: Article

References (40)

1. 1 Kurscheid T, Lauterbach K. The cost implications of obesity for health care and society. Int J Obes Relat Metab Disord 1998;22:S3-S6.
2. 2 Rossner S. Defining success in obesity management. Int J Obes Relat Metab Disord 1997;21:S2-S4.
3. 3 Solomon CG, Mantero F. Obesity and mortality: a review of the epidemiologic data. Am J Clin Nutr 1997;66:1044S-50S.
4. 4 Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J, Sniderman AD. The adipsin-acylation stimulating protein system in human adipocytes: Regulation of triacylglycerol synthesis. Biochemistry 1994;33:9489-95.
5. 5 Murray I, Parker RA, Kirchgessner TG, et al. Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin. J Lipid Res 1997;38:2492-501.
6. 6 Cianflone K, Sniderman AD, Walsh MJ, Vu H, Gagnon J, Rodriguez MA. Purification and characterization of acylation stimulating protein. J Biol Chem 1989;264:426-30.
7. 7 Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M, Rodriguez MA. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991;26:495-9.
8. 8 Maslowska M, Sniderman AD, Germinario R, Cianflone K. ASP stimulates glucose transport in cultured human adipocytes. Int J Obes 1997;21:261-6.
9. 9 Germinario R, Sniderman AD, Manuel S, Pratt S, Baldo A, Cianflone K. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation stimulating protein. Metabolism 1993;40:574-80.
10. 10 Tao YZ, Cianflone K, Sniderman AD, Colby-Germinario SP, Germinario RJ. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim Biophys Acta 1997;1344:221-9.
11. 11 Flier JS. The adipocyte: storage depot or node on the energy information superhighway (Review)? Cell 1995;80:15-8.
12. 12 Després JP, Macdonald I. (editors). Abstracts. Eighth international congress on obesity. Paris, France. 29 August to 3 September. Int J Obes Relat Metab Disord 1998;22.
13. 13 Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem 1992;267:12736-41.
14. 14 Choy LN, Spiegelman BM. Regulation of alternative pathway activation and C3a production by adipose cells. Obes Res 1996;4:521-32.
15. 15 Cianflone K, Maslowska M. Differentiation induced production of ASP in human adipocytes. Eur J Clin Invest 1995;25:817-25.
16. 16 Peake PW, O'Grady S, Pussell BA, Charlesworth JA. Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur J Clin Invest 1997;27:922-7.
17. 17 Baldo A, Sniderman AD, St-Luce S, et al. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993;92:1543-7.
18. 18 Hugli TE. Structure and function of C3a anaphylatoxin. Curr Top Microbiol Immunol 1989;153:181-208.
19. 19 Cook KS, Min HY, Johnson D, et al. Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science 1987;237:402-5.
20. 20 Johnson PR, Spiegelman B, Rosen B, Turkenkopf I, Ree H, Greenwood MR. Reduced adipsin mRNA and circulating adipsin protein are modulated by adrenal steroids in obese Zucker rats. Am J Physiol 1990;259:R184-8.
21. 21 Napolitano A, Lowell BB, Damm D, et al. Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. Int J Obes Relat Metab Disord 1994;18: 213-8.
22. 22 Maslowska M, Scantlebury T, Germinario R, Cianflone K. Acute in vitro production of ASP in differentiated adipocytes. J Lipid Res 1997;38:21-31.
23. 23 Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD, Frayn KN. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 1998;39:884-91.
24. 24 Sniderman AD, Cianflone K, Eckel RH. Levels of acylation stimulating protein in obese women before and after moderate weight loss. Int J Obes 1991;15:333-6.
25. 25 Cianflone K, Sniderman AD, Kalant D, Marliss EB, Gougeon R. Response of plasma ASP to a prolonged fast. Int J Obes 1995;19:604-9.
26. 26 Kohen Avramoglu R, Cianflone K, Sniderman AD. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells. J Lipid Res 1995;36:2513-28.
27. 27 Contois JH, McNamara JR, Lammi-Keefe CJ, Wilson PW, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. Clin Chem 1996;42:515-23.
28. 28 Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
29. 29 Stove S, Klos A, Bautsch W, Kohl J. Re-evaluation of the storage conditions for blood samples which are used for determination of complement activation. J Immunol Methods 1995;182:1-5.
30. 30 Moxley G, Ruddy S. Elevated plasma C3 anaphylatoxin levels in rheumatoid arthritis patients. Arthritis Rheum 1987,30:1097-104.
31. 31 Cianflone K, Zhang XJ, Genest J Jr, Sniderman AD. Plasma acylation stimulating protein in coronary artery disease. Arterio, Thromb Vasc Biol 1997;17:1239-44.
32. 32 Cianflone K. The Acylation Stimulating Protein Pathway. Clin Implicat Clin Biochem 1997;30:301-12.
33. 33 Cianflone K, Maslowska M, Sniderman A. The acylation stimulating protein-adipsin system (Review). Int J Obes Relat Metab Disord 1995;19 (Suppl. 1):S34-8.
34. 34 Rosen BS, Cook KS, Yaglom J, et al. Adipsin and complement factor D activity: an immune-related defect in obesity. Science 1989;244:1483-7.
35. 35 Pomeroy C, Mitchell J, Eckert E, Raymond N, Crosby R, Dalmasso AP. Effect of body weight and calorie restriction on serum complement proteins, including factor D/adipsin: studies in anorexia nervosa and obesity. Clin Exp Immunol 1997;108:507-15.
36. 36 Wirthmueller U, Dewald B, Thelen M, et al. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol 1997;158:4444-51.
37. 37 Walsh MJ, Sniderman AD, Cianflone K, Vu H, Rodriguez MA, Forse RA. The effect of ASP on the adipocyte of the morbidly obese. J Surg Res 1989;46:470-3.
38. 38 Saleh J, Christou N, Cianflone K. Regional specificity of ASP binding in human adipose tissue. Am J Physiol (Endo Metab) 1999; (in press).
39. 39 Scheen AJ, Paquot N, Letiexhe MR, Paolisso G, Castillo MJ, Lefebvre PJ. Glucose metabolism in obese subjects: lessons from OGTT, IVGTT and clamp studies. Int J Obes Relat Metab Disord 1995;19:S14-S20.
40. 40 Letiexhe MR, Scheen AJ, Gerard PL, Desaive C, Lefebvre PJ. Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects. Int J Obes Relat Metab Disord 1994;18:295-300.